Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research
August 05, 2011
Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research
The firm, Proteomedix Frontiers, has developed SRM-MS assays for more than 400 proteins that could be important to drug development efforts. It plans to offer them to pharma researchers both as kits and through agreements with contract research organizations.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
August 12, 2011 / ProteoMonitor - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - Leigh Anderson Launches New Firm to Commercialize SISCAPA Technology
June 17, 2011 / ProteoMonitor - Taking Aim at Clinical Oncology Market, Proteome Sciences Developing SRM-MS Assay for ER Status
July 22, 2011 / ProteoMonitor - ETH Team Publishes Method for High-Throughput Quantitation of Whole Proteomes
July 22, 2011 / ProteoMonitor